These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23736031)

  • 21. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.
    De Grandis V; Bizzarri AR; Cannistraro S
    J Mol Recognit; 2007; 20(4):215-26. PubMed ID: 17703463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does azurin bind to the transactivation domain of p53? A Trp phosphorescence study.
    Gabellieri E; Bucciantini M; Stefani M; Cioni P
    Biophys Chem; 2011 Dec; 159(2-3):287-93. PubMed ID: 21885181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53.
    Demma M; Maxwell E; Ramos R; Liang L; Li C; Hesk D; Rossman R; Mallams A; Doll R; Liu M; Seidel-Dugan C; Bishop WR; Dasmahapatra B
    J Biol Chem; 2010 Apr; 285(14):10198-212. PubMed ID: 20124408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
    Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
    J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p28 Bacterial Peptide, as an Anticancer Agent.
    Yaghoubi A; Khazaei M; Avan A; Hasanian SM; Cho WC; Soleimanpour S
    Front Oncol; 2020; 10():1303. PubMed ID: 32850408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination.
    Bhatt P; d'Avout C; Kane NS; Borowiec JA; Saxena A
    FEBS J; 2012 Feb; 279(3):370-83. PubMed ID: 22103682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
    Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH
    Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-Resolved Fluorescence and Essential Dynamics Study on the Structural Heterogeneity of p53DBD Bound to the Anticancer p28 Peptide.
    Bizzarri AR; Cannistraro S
    J Phys Chem B; 2020 Nov; 124(44):9820-9828. PubMed ID: 33103427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
    Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
    Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-induced CRL4
    Su Y; Luo Y; Zhang P; Lin H; Pu W; Zhang H; Wang H; Hao Y; Xiao Y; Zhang X; Wei X; Nie S; Zhang K; Fu Q; Chen H; Huang N; Ren Y; Wu M; Chow BKC; Chen X; Jin W; Wang F; Zhao L; Rao F
    Mol Cell; 2023 Jul; 83(13):2316-2331.e7. PubMed ID: 37390815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
    Corcoran CA; Montalbano J; Sun H; He Q; Huang Y; Sheikh MS
    J Biol Chem; 2009 Aug; 284(33):21955-21970. PubMed ID: 19483087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity.
    Goto M; Yamada T; Kimbara K; Horner J; Newcomb M; Gupta TK; Chakrabarty AM
    Mol Microbiol; 2003 Jan; 47(2):549-59. PubMed ID: 12519204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
    J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma.
    Lee YH; Andersen JB; Song HT; Judge AD; Seo D; Ishikawa T; Marquardt JU; Kitade M; Durkin ME; Raggi C; Woo HG; Conner EA; Avital I; Maclachlan I; Factor VM; Thorgeirsson SS
    Cancer Res; 2010 Nov; 70(21):8264-9. PubMed ID: 20959491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
    Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.
    Su WJ; Fang JS; Cheng F; Liu C; Zhou F; Zhang J
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1720-5. PubMed ID: 23319651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.